日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial

部分肾切除术:一项针对临床局限性肾细胞癌的随机试验,旨在评估复杂部分肾切除术与根治性肾切除术的临床和成本效益。

Johnson, Diana; Thomas, Ruth; Cotton, Seonaidh; Newlands, Rumana; Cooper, David; McCann, Sharon; Vale, Luke; Gillies, Katie; Bex, Axel; Challacombe, Ben; Falloon, Jemma; MacLennan, Graeme; Narahari, Krishna; Nicol, David; Sheerin, Neil; Stewart, Grant D; Tran, Maxine; Heer, Rakesh; Soomro, Naeem

Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer.

结合空间转录组学、伪时间和机器学习技术,可以发现前列腺癌的生物标志物

Smelik Martin, Diaz-Roncero Gonzalez Daniel, An Xiaojing, Heer Rakesh, Henningsohn Lars, Li Xinxiu, Wang Hui, Zhao Yelin, Benson Mikael

Detection of urothelial carcinoma in Lynch syndrome using microsatellite instability analysis of urine cell-free DNA.

利用尿液游离DNA的微卫星不稳定性分析检测林奇综合征中的尿路上皮癌。

Hall Rebecca, Gallon Richard, Hayes Christine, Herrero-Belmonte Patricia, Phelps Rachel, Job Donna, Wake Ruth, Ferrier Mary, Turner Helen, O'Donnell Rachel, Nambiar Arjun, Rai Bhavan, Martin Richard, McAnulty Ciaron, Santibanez-Koref Mauro, Heer Rakesh, Jackson Michael S, Burn John

Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos.

ARID1A 的缺失通过与 AP1 亚基 cFos 的协同作用,加速前列腺肿瘤的发生,并使其呈现增殖性胶原蛋白缺乏的表型

Hartley Andrew, Galbraith Laura C A, Shaw Robin, Tibbo Amy, Veeratterapillay Rajan, Wilson Laura, Heer Rakesh, Blyth Karen, Leung Hing, Ahmad Imran

FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.

FUT8 是前列腺肿瘤生长的关键驱动因素,可以使用岩藻糖基化抑制剂进行靶向治疗

Bastian Kayla, Orozco-Moreno Margarita, Thomas Huw, Hodgson Kirsty, Visser Eline A, Rossing Emiel, Pijnenborg Johan F A, Eerden Nienke, Wilson Laura, Saravannan Hasvini, Hanley Oliver, Grimsley Grace, Frame Fiona, Peng Ziqian, Knight Bridget, McCullagh Paul, McGrath John, Crundwell Malcolm, Harries Lorna, Maitland Norman J, Heer Rakesh, Wang Ning, Goddard-Borger Ethan D, Guerrero Ramon Hurtado, Boltje Thomas J, Drake Richard R, Scott Emma, Elliott David J, Munkley Jennifer

A retrospective cohort study assessing medication coverage in patients with prostate cancer prescribed luteinizing hormone releasing hormone (LHRH) agonists in England

一项回顾性队列研究评估了英国前列腺癌患者接受促黄体生成素释放激素 (LHRH) 激动剂治疗的药物覆盖情况。

Sayers, Ian; Joao Carvalho, Sara; Davidson, Jennifer; Elster, Naomi; Heer, Rakesh; Raja, Mohammad; Higgs, Kate; Nolan, Andrew; Sassmann, Jelena

Utilisation of artificial intelligence to enhance the detection rates of renal cancer on cross-sectional imaging: protocol for a systematic review and meta-analysis

利用人工智能提高横断面影像学肾癌检出率:系统评价和荟萃分析方案

Ofagbor, Ojone; Bhardwaj, Gaurika; Zhao, Yi; Baana, Mohamed; Arkwazi, Murtada; Lami, Mariam; Bolton, Eva; Heer, Rakesh

Emerging tools for the early detection of prostate cancer

用于前列腺癌早期检测的新兴工具

Haider, Muhammad; Leow, Jeffrey J; Nordström, Tobias; Mortezavi, Ashkan; Albers, Peter; Heer, Rakesh; Rajan, Prabhakar

AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses

人工智能预测非肌层浸润性膀胱癌复发:系统评价及其研究优势与不足

Abbas, Saram; Shafik, Rishad; Soomro, Naeem; Heer, Rakesh; Adhikari, Kabita

Using artificial intelligence for bladder cancer detection during cystoscopy and its impact on clinical outcomes: a protocol for a systematic review and meta-analysis

利用人工智能在膀胱镜检查中检测膀胱癌及其对临床结果的影响:系统评价和荟萃分析方案

Baana, Mohamed; Arkwazi, Murtada; Zhao, Yi; Ofagbor, Ojone; Bhardwaj, Gaurika; Lami, Mariam; Bolton, Eva; Heer, Rakesh